Metraipolis › archive › dc_339a4317e4bc

Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects — Europe PMC PMID:41710748

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41710748
DOI
10.1021/acsptsci.5c00719
License (as archived)
solo-consultazione
Archived
2026-11-06T12:49:55.775Z
SHA-256 of the archived text
c50abfe75b2946e26b93207e07e283a4c7a7ba1e97ad2ce8063827b0857ce9a0
Stable URL of this page
https://metraipolis.com/documento/dc_339a4317e4bc

How to cite

Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects — Europe PMC PMID:41710748 — Europe PMC (en), https://europepmc.org/article/MED/41710748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_339a4317e4bc (Metraipolis archive dc_339a4317e4bc, sha256 c50abfe75b2946e26b93207e07e283a4c7a7ba1e97ad2ce8063827b0857ce9a0)
BibTeX
@misc{dc339a4317e4bc,
  title = {Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects — Europe PMC PMID:41710748},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41710748},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_339a4317e4bc; sha256 c50abfe75b2946e26b93207e07e283a4c7a7ba1e97ad2ce8063827b0857ce9a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41710748. Agents can read the archived copy with the MCP tool read_document.